BiotechTube

Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Salmeterol MDI + Placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

COPD

Conditions

COPD

Trial Timeline

Feb 1, 2002 โ†’ Jun 1, 2003

NCT ID
NCT00685841

About Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Salmeterol MDI + Placebo

Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Salmeterol MDI + Placebo is a phase 3 stage product being developed by Sumitomo Pharma for COPD. The current trial status is completed. This product is registered under clinical trial identifier NCT00685841. Target conditions include COPD.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00685841Phase 3Completed

Competing Products

20 competing products in COPD

See all competitors
ProductCompanyStageHype Score
Sitafloxacin + Moxifloxacin HydrochlorideDaiichi SankyoApproved
85
Reldesemtiv + PlaceboAstellas PharmaPhase 2
52
Lysozyme hydrochloride + PlaceboEisaiApproved
85
Arformoterol (Brovana) + PlaceboSumitomo PharmaApproved
85
Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Placebo + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + PlaceboSumitomo PharmaPhase 2
52
Arformoterol tartrate inhalation solution + TiotropiumSumitomo PharmaApproved
85
Racemic formoterol + Arformoterol tartrate inhalation solution + Racemic formoterolSumitomo PharmaPhase 2
52
Levalbuterol HCl + Levalbuterol HCl + Albuterol Sulfate + PlaceboSumitomo PharmaPhase 3
77
Formoterol Turbuhaler + Budesonide/Formoterol Turbuhaler + Formoterol TurbuhalerAstraZenecaPhase 1
33
AZD2115 + Placebo + Indacaterol + Indacaterol + TiotropiumAstraZenecaPhase 2
52
RoflumilastAstraZenecaPhase 2/3
65
Aclidinium bromide + PlaceboAstraZenecaPhase 3
77
RoflumilastAstraZenecaPre-clinical
23
Symbicort (budesonide/formoterol turbuhaler 320/9ug) + Spiriva (tiotropium bromide 18ug)AstraZenecaApproved
85
AZD7624 + Placebo to matchAstraZenecaPhase 1
33
Roflumilast + PlaceboAstraZenecaPhase 3
77
Aclidinium bromide 100 ฮผg bid + Aclidinium bromide 200 ฮผg bid + Aclidininum bromide 400 ฮผg bid + Placebo + Formoterol 12 ฮผg bidAstraZenecaPhase 2
52
ACL/FOR + PlaceboAstraZenecaApproved
85
TozorakimabAstraZenecaPhase 2
52
AZD1981 + PlaceboAstraZenecaPhase 2
52

Other Products from Sumitomo Pharma

BlonanserinApproved
85
Mosapride + domperidoneApproved
85
levalbuterol HCl + albuterol SulfateApproved
85
LurasidoneApproved
85
placebo, isotonic ciclesonide, hypotonic ciclesonideApproved
85